Your own cells, reborn: a new hope for Parkinson's?

NCT ID NCT06344026

First seen May 17, 2026 ยท Last updated May 17, 2026

Summary

This early-stage trial tests the safety of a new treatment called ANPD001 for people with Parkinson's disease. The treatment uses a patient's own skin cells to create new dopamine-producing cells, which are then injected into the brain. The study involves 9 participants and aims to see if the procedure is safe and tolerable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Feinstein Institutes

    Manhasset, New York, 11030, United States

  • Scripps Health

    La Jolla, California, 92037, United States

  • University of Arizona - Banner Health

    Tucson, Arizona, 85724, United States

  • University of California, Irvine

    Orange, California, 92868, United States

  • University of California, Los Angeles

    Los Angeles, California, 90095, United States

  • University of California, San Diego

    San Diego, California, 92037, United States

  • University of California, San Francisco

    San Francisco, California, 94143, United States

  • University of Colorado

    Aurora, Colorado, 80045, United States

Conditions

Explore the condition pages connected to this study.